Instituto de Ciencias Biomédicas, Facultad Ciencias de la Salud, Universidad Autónoma de Chile, Santiago 8910060, Chile.
Computational and Theoretical Chemistry Group, Departamento de Ciencias Químicas, Facultad de Ciencias Exactas, Universidad Andres Bello, Santiago 8370251, Chile.
Genes (Basel). 2020 Feb 18;11(2):206. doi: 10.3390/genes11020206.
The expression of is dependent on oxygen levels, glucose concentration, and cell cycle progression. This gene encodes for protein HIG2A, found in mitochondria and the nucleus, promoting cell survival in hypoxic conditions. The genomic location of is in chromosome 5q35.2, where several chromosomal abnormalities are related to numerous cancers. The analysis of high definition expression profiles of suggests a role for HIG2A in cancer biology. Accordingly, the research objective was to perform a molecular biosystem analysis of aiming to discover HIG2A implications in cancer biology. For this purpose, public databases such as SWISS-MODEL protein structure homology-modelling server, Catalogue of Somatic Mutations in Cancer (COSMIC), Gene Expression Omnibus (GEO), MethHC: a database of DNA methylation and gene expression in human cancer, and microRNA-target interactions database (miRTarBase) were accessed. We also evaluated, by using Real-Time Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR), the expression of gene in healthy bone marrow-liver-spleen tissues of mice after quercetin (50 mg/kg) treatment. Thus, among the structural features of HIG2A protein that may participate in HIG2A translocation to the nucleus are an importin -dependent nuclear localization signal (NLS), a motif of DNA binding residues and a probable SUMOylating residue. gene is not implicated in cancer via mutation. In addition, DNA methylation and mRNA expression of gene present significant alterations in several cancers; gene showed significant higher expression in Diffuse Large B-cell Lymphoma (DLBCL). Hypoxic tissues characterize the "bone marrow-liver-spleen" DLBCL type. The relative quantification, by using RT-qPCR, showed that expression is higher in bone marrow than in the liver or spleen. In addition, it was observed that quercetin modulated the expression of gene in mice. As an assembly factor of mitochondrial respirasomes, HIG2A might be unexpectedly involved in the change of cellular energetics happening in cancer. As a result, it is worth continuing to explore the role of in cancer biology.
的表达依赖于氧水平、葡萄糖浓度和细胞周期进程。该基因编码蛋白 HIG2A,存在于线粒体和细胞核中,在缺氧条件下促进细胞存活。的基因组位置位于 5q35.2 染色体上,其中几个染色体异常与多种癌症有关。对高清晰度表达谱的分析表明 HIG2A 在癌症生物学中具有重要作用。因此,研究目的是对进行分子生物系统分析,以发现 HIG2A 在癌症生物学中的作用。为此,我们访问了公共数据库,如 SWISS-MODEL 蛋白质结构同源建模服务器、癌症体细胞突变目录 (COSMIC)、基因表达综合数据库 (GEO)、MethHC:人类癌症中 DNA 甲基化和基因表达数据库,以及 microRNA 靶标相互作用数据库 (miRTarBase)。我们还通过实时定量逆转录聚合酶链反应 (qRT-PCR) 评估了槲皮素 (50mg/kg) 处理后小鼠健康骨髓-肝-脾组织中基因的表达。因此,HIG2A 蛋白的结构特征中,可能参与 HIG2A 核转位的有依赖于输入蛋白的核定位信号 (NLS)、DNA 结合残基的基序和一个可能的 SUMO 化残基。基因不通过突变参与癌症。此外,在几种癌症中,基因的 DNA 甲基化和 mRNA 表达均发生显著改变;基因在弥漫性大 B 细胞淋巴瘤 (DLBCL) 中表达显著升高。缺氧组织是“骨髓-肝-脾”DLBCL 类型的特征。通过 RT-qPCR 的相对定量显示,基因在骨髓中的表达高于肝脏或脾脏。此外,还观察到槲皮素调节了小鼠中基因的表达。作为线粒体呼吸体的组装因子,HIG2A 可能出乎意料地参与了癌症中发生的细胞能量变化。因此,值得继续探索在癌症生物学中的作用。